BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25841099)

  • 1. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Liu Y; Zhang L; Santoro C; Song J; Rodriguez A; Wang L
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010810. PubMed ID: 25841099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010810. PubMed ID: 28685500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for treating inhibitors in people with inherited severe hemophilia.
    Jiang L; Liu Y; Zhang L; Santoro C; Rodriguez A
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD010810. PubMed ID: 32761818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003429. PubMed ID: 15846666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B.
    Athale AH; Marcucci M; Iorio A
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010561. PubMed ID: 24763974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Stobart K; Iorio A; Wu JK
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003429. PubMed ID: 16625581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
    Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
    Cochrane Database Syst Rev; 2015 Feb; (2):CD009961. PubMed ID: 25922858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Zeng Y; Zhou R; Duan X; Long D
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011907. PubMed ID: 27387850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.
    Iorio A; Marchesini E; Marcucci M; Stobart K; Chan AK
    Cochrane Database Syst Rev; 2011 Sep; (9):CD003429. PubMed ID: 21901684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors.
    Chai-Adisaksopha C; Nevitt SJ; Simpson ML; Janbain M; Konkle BA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011441. PubMed ID: 28944952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
    Matino D; Makris M; Dwan K; D'Amico R; Iorio A
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004449. PubMed ID: 26677005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Neely JA; Kalipatnapu S
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010822. PubMed ID: 25394678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor eradication with rituximab in haemophilia: where do we stand?
    Franchini M; Mannucci PM
    Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010822. PubMed ID: 27996087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for haemophilia.
    Sharma A; Easow Mathew M; Sriganesh V; Reiss UM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010822. PubMed ID: 32342499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for adolescents with haemophilia and high titre inhibitors.
    Fox RA; Neufeld EJ; Bennett CM
    Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
    Iorio A; Matino D; D'Amico R; Makris M
    Cochrane Database Syst Rev; 2010 Aug; (8):CD004449. PubMed ID: 20687076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab for eradicating inhibitors in people with acquired haemophilia A.
    Remmington T; Smith S
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011907. PubMed ID: 34423414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and foetal outcomes following natural vaginal versus caesarean section (c-section) delivery in women with bleeding disorders and carriers.
    Karanth L; Kanagasabai S; Abas AB
    Cochrane Database Syst Rev; 2015 Apr; (4):CD011059. PubMed ID: 25835707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reversal of inhibitors in congenital hemophilia.
    DeFrates SR; McDonagh KT; Adams VR
    Pharmacotherapy; 2013 Feb; 33(2):157-64. PubMed ID: 23355059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.